Navigation Links
Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
Date:2/5/2013

SAN DIEGO, Feb. 5, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, today announced its intention to redeem two classes of outstanding warrants initially issued to investors participating in private placement financings in 2011 and 2012.  The warrant redemption will raise non-dilutive capital, enable Organovo to significantly improve its balance sheet, help position the Company to qualify to list its common stock on the NYSE MKT or NASDAQ exchange, and decrease a significant portion of the derivative liability from its balance sheet.

A Notice of Redemption was mailed to affected warrant holders on February 5, 2013.  These warrant holders will have until 5:00 p.m. ET on March 14, 2013, to exercise their outstanding warrants at $1.00 per share.  Thereafter, any warrants that remain unexercised will automatically be redeemed by the company at a redemption price of $0.0001 per share of common stock then issuable upon exercise of the redeemed warrant.  Approximately 2.9 million warrant shares are affected by this Notice of Redemption.

Previously, on December 21, 2012, the Company completed a tender offer including the same warrants.  At that time, approximately two-thirds of warrant holders elected to participate in the tender offer and exercised their warrants at $0.80 per share.  The current Notice of Redemption was given to the remaining warrant holders at the Company's option following the qualifying event of its common stock trading at $2.50 per share or higher for twenty (20) consecutive trading days.  If all warrant holders elect to exercise their warrants prior to the redemption date, approximately $2.9 million of additional equity capital will be raised by the Company without any increase to its fully diluted shares.  If no
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Organovo Holdings Appoints James T. Glover to Board of Directors
2. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
3. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
5. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
6. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
7. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
8. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
9. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
10. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
11. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 ... the "Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, ... and Reagents], Application (Immunology, Oncology) & by ... published by MarketsandMarkets, provides a detailed overview ... current market trends, and strategies impacting the ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 The ... Growing ageing population and rise in the incidence of ... chronic wounds and in affordability of better quality of ... wound care market. Universal coverage of public health insurance ... would further stimulate demand. Based on the findings of ...
(Date:9/30/2014)... 2014 BioStructures, LLC has been awarded ... Tissue Banks (AATB), it was announced today by ... Accreditation follows an intensive nine-month process, including ... inspector.  It establishes that the level of medical, ... or exceeds the standards set by the AATB.  ...
Breaking Medicine Technology:Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4China Wound Care Market 2China Wound Care Market 3Biostructures, LLC Earns AATB Accreditation 2
(Date:9/30/2014)... Federally Qualified Health Centers (FQHCs) granted new patient ... higher rates than other primary care practices (non-FQHCs), ... to results of a new 10-state University of ... Care . , Using data from a previous ... the investigators found that FQHCs community health ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Glycodrive ... Star Nutraceuticals designed to help maximize lean, strong muscle ... the body’s absorption of glucose has caught the attention ... “The main purpose behind Glycodrive is to help the ... muscle,” reports Michaels. “Carbs are essential in the muscle-building ...
(Date:9/30/2014)... N.C. (PRWEB) September 30, 2014 The ... an option to help diabetics curb their sweet tooth, ... Nature this September, suggests that zero-calorie sweeteners ... type 2 diabetes. , The Weizmann Institute of ... they fed artificial sweeteners to mice, the mice developed ...
(Date:9/30/2014)... 2014 With the flu season ... every day, it’s a perfect time to announce ... system is an electro-static disinfectant delivery system that ... normally missed with spray-on disinfectant applicators. , The ... an electrostatic negative charge to the disinfecting solution. ...
(Date:9/30/2014)... September 30, 2014 Two revolutionary procedures now ... treatment of gum disease a far less painful and ... , “If you’ve ever felt electric shock waves surge through ... a cold beverage, it’s possible you already know the impact ... is a general dentist in West Palm Beach, and a ...
Breaking Medicine News(10 mins):Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... and Bioengineering (NIBIB) Laboratory of Bioengineering and Physical Science ... visualize fine details of cell structure three-dimensionally in thick ... organized and how they function. The work is described ... Nature Methods . The new electron tomography ...
... , , ... GTIV ), a leading provider of comprehensive home health ... the Company,s Board of Directors: Philip R. Lochner, Jr., Sheldon ... appointments, Gentiva has re-established an independent majority on its Board ...
... - NUCRYST Pharmaceuticals, a developer and manufacturer of ... Wound Management division of Smith Nephew ... Flex3 and Acticoat(TM) Flex7. The Flex range is ... dressings with NUCRYST,s proprietary SILCRYST(TM) nanocrystalline silver coatings. ...
... , , NEW YORK, Sept. ... is hosting a kick off cocktail reception to announce its Second ... the National Football League. The main event, The Journey of ... Rock Cafe with actress Lorraine Bracco and comedian Penny Marshall serving ...
... CAMBRIDGE, Mass., Sept. 3 Satori Pharmaceuticals Incorporated ... disease, Parkinson,s disease, and other neurodegenerative disorders, today announced that ... its Board of Directors. , , "We ... to our board," said Dr. Jeffrey Ives, Satori CEO. ...
... , , MIAMI BEACH, ... Oprah have spent years yo-yo dieting, but would they work so ... the extra pounds? These days, Fat is Fabulous, with reality shows ... zaftig women competing in dance-offs, bringing in big ratings numbers for ...
Cached Medicine News:Health News:NIBIB scientists increase imaging efficiency in cell structure studies 2Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 2Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 3Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 4Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 5Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 6Health News:European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew 2Health News:European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew 3Health News:European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew 4Health News:Brain Injury Association of New York State to Host Kick Off Cocktail Reception 2Health News:Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors 2Health News:Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors 3Health News:Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors 4Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 2Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 3Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: